4th Quarter - Termination

MEHLMAN CONSULTING, INC. for MERCK AND CO INC

Firm
Client
Income
$40,000
Expenses
—
Terminated
Dec 31, 2013

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 22, 2014 $40,000 Replaced
4th Quarter - Termination (this page) Jan 27, 2014 $40,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1407, Annual Drug User Fee Agreements of 2013. Drug Quality and Security Act (Became P.L. 113-54 on 11/27/13).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1407 (113th)

Medicare/Medicaid MMM

Budget issues, including Medicare Part D rebates and reductions in Medicare Part D low income subsidies. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board. Medicare and Entitlement Reform. Low income subsidy co-pays.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Tax issues: comprehensive tax reform, deferral and transfer pricing. Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11). Base erosion.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Trans-Pacific Partnership. Biologic data exclusivity. TTIP (US-EU trade bill). Trade promotion authority. Trade with India.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.